Abstract
SUMMARY: Intracranial dural AVFs are abnormal communications between arteries that supply the dura mater and draining cortical veins or venous sinuses. They are believed to form as a response to venous insults such as thrombosis, trauma, or infection. Classification and management are dependent on the presence of drainage/reflux into cortical veins because such drainage markedly elevates the risk of hemorrhage or venous congestion, resulting in neurologic deficits. AVFs with tolerable symptoms and benign drainage patterns can be managed conservatively. Intolerable symptoms, presentation with hemorrhage/neurologic deficits, or aggressive drainage patterns are indications for intervention. Treatment options include microsurgical disconnection, endovascular transarterial embolization, transvenous embolization, or a combination. This is the first in a series of 3 articles on endovascular management of intracranial dural AVFs, in which we outline the principles and outcomes of endovascular treatment.
ABBREVIATIONS:
- dAVF
- dural AVF
- ECA
- external carotid artery
- GKRS
- gamma knife radiosurgery
- TA
- transarterial
- TV
- transvenous
This is the first in a series of 3 articles on the endovascular management of intracranial dural AVFs (dAVFs) based on our experience in treating these lesions during the past 25 years at Toronto Western Hospital. In this introductory article, we outline the epidemiology, classification, diagnosis, and management principles. In the following 2 articles, we detail the principles of transarterial and transvenous embolization, respectively.
Definition
Intracranial dAVFs are abnormal direct vascular communications between arteries that supply the dura mater and draining cortical veins or dural venous sinuses, without a normal intervening capillary network.1⇓-3
Arterial supply may be composed of a single feeder or multiple feeders.1,2 The supplying arteries most often originate external to the dura mater (eg, the middle meningeal artery arising from the internal maxillary artery)1 but can less commonly arise from intradural pial artery branches, which are known to supply dural structures (eg, the artery of Davidoff and Schechter arising from the posterior cerebral artery and supplying the inferior medial tentorium).4⇓⇓–7 Secondary induced pial supply from vessels that do not normally supply the dura is well-described in the literature;4 however, if these vessels are the sole arterial supply, the lesion is, by definition, a pial vascular malformation rather than a dAVF.1,4
Venous drainage can be directly into cortical veins, directly into the dural venous sinuses, or into dural venous sinuses with reflux into the cortical veins.2,3,8 Possible arterial supply and venous drainage patterns are demonstrated in Fig 1.
Epidemiology
Intracranial dAVFs are rare lesions with a detection rate of <1 per 100,000 persons in any given year across a variety of populations (0.16–0.51).9⇓-11 Clinical presentation is most often between 50 and 70 years of age, and there is a mild female predominance (female/male ratio, 11:9).9⇓⇓-12 dAVFs represent approximately 10%–15% of all intracranial vascular malformations.1,9,13 The most common locations (in descending order) are the transverse-sigmoid sinus, cavernous sinus, and tentorium.2,11,12,14
Intracranial hemorrhage is the initial clinical presentation in 12%–18% of cases.2,11,12,14 Risk factors for hemorrhagic presentation (in descending order of risk) include previous hemorrhage, cortical venous reflux, cortical venous ectasia, location (craniocervical junction, tentorium, transverse-sigmoid sinus, anterior cranial fossa, superior sagittal sinus), and male sex.2,8,12 Nonhemorrhagic neurologic deficits (including focal deficits, encephalopathy, and seizures) represent 12%–20% of clinical presentations and are also associated with cortical venous reflux and intracranial venous hypertension.8,12,14 Direct cortical venous drainage, cortical venous reflux, and hemorrhagic presentation are more common in men.2,8
The pathogenesis of dural AVFs is debated, but pathology involving the intracranial venous system appears to play a central role.13 Such pathology can include prothrombotic disorders and hormonal states predisposing to venous sinus occlusion (including pregnancy), previous cranial surgery, trauma, chronic venous hypertension, and infection such as mastoiditis adjacent to the sigmoid sinus.15,16 Venous sinus thrombosis with venous hypertension is thought to promote formation of dural AVFs via ischemia-related angiogenesis.17
Classification
Both Cognard et al2 and Borden et al3 demonstrated that the natural history of dAVFs was related to the pattern of venous drainage, and this was the basis for their respective classification systems. In both classification systems, dAVFs can be broadly divided into benign (Borden I, Cognard I–IIa) and aggressive (Borden II–III, Cognard IIb–V) patterns of venous drainage (Table).2,3 Benign venous drainage is characterized by drainage into the dural venous sinuses without cortical venous reflux. Aggressive venous drainage is characterized by cortical venous reflux (Borden II, Cognard IIb) or direct cortical venous drainage ± ectasia (Borden III, Cognard III–IV). An aggressive venographic pattern strongly correlates with and predicts the occurrence of intracranial hemorrhage and nonhemorrhagic neurologic deficits.2,3,8 These venous drainage patterns are demonstrated in Fig 1B.
In addition to the above classification schemes based on the presence of venous reflux, dAVFs can also be classified on the basis of their anatomic location and the embryologic epidural compartment into which they drain. The Lasjaunias-Geibprasert classification system was proposed in 2008, dividing cranial and spinal dAVFs into 3 embryologically determined epidural drainage compartments (ventral, dorsal, and lateral epidural types).18 Each of these drainage patterns are associated with differing sex distributions, rates of cortical venous reflux, and clinical presentations (benign versus aggressive).18 The utility of this classification system is the ability to understand the anatomic-embryologic basis for the aggressive behavior of a dAVF and to help predict the natural history based on location. Therefore, it does not replace the important Borden or Cognard systems, but rather provides additional information.
Ventral epidural drainage (eg, basiocciput, sigmoid sinus) involves drainage toward the extracranial ventral venous plexuses, is more common in women, and has a more benign presentation. Dorsal epidural drainage (eg, transverse sinus, superior sagittal sinus) typically involves drainage into dural venous sinuses. Lateral epidural drainage (eg, petrous, ethmoid, falcotentorial junction) is the most aggressive group due to drainage directly into cortical veins.18 These lateral epidural locations are more commonly affected in men.12,19,20 Therefore, the higher rate of hemorrhagic presentation in men may be explained by the relatively sex-specific anatomic distribution of dAVFs and aggressive venous drainage patterns seen in the lateral epidural group.2,8,18
Natural History
In benign dAVFs (Borden I, Cognard I–IIa), Gross and Du,8 in 2012, demonstrated no intracranial hemorrhages or new neurologic deficits during 409 lesion-years of follow-up. This was consistent with the original findings of Cognard et al,2 in 1995, who reported nonaggressive clinical presentations in 83 of 84 patients with type I dAVFs and no intracranial hemorrhages in 111 patients with type I–IIa dAVFs. Asymptomatic or minimally symptomatic patients, regardless of classification status, have a low annual hemorrhage risk of 2%.8
On the other hand, the odds ratio of intracranial hemorrhage in patients with cortical venous reflux is 17.5.12 The Toronto Brain Vascular Malformation Study Group previously reported clinical outcomes in untreated or undertreated patients with cortical venous reflux, identifying an annual nonhemorrhagic neurologic deficit rate of 6.9%, an annual hemorrhage rate of 8.1%, an annual mortality rate of 10.4%, and a total annual event rate of 15%.21
Studies on the natural history of dAVFs stratified by venous drainage patterns report annual hemorrhage rates of 6% with cortical venous reflux, 10% with direct cortical venous drainage, and 21% with cortical venous ectasia.8 A nonhemorrhagic neurologic deficit at initial presentation is associated with a 10% annual hemorrhage rate and an initial hemorrhagic presentation with a 46% future annual hemorrhage rate.8 The highest risk period for rebleeding is within the first 2 weeks after the initial hemorrhage (up to 35%),22 suggesting that these patients should be treated more acutely.
Diagnosis
Consideration of a diagnosis of dAVF may be based initially on the clinical presentation and noncontrast imaging findings. Clinical presentations of nonhemorrhagic dAVFs include pulsatile tinnitus (particularly for lesions adjacent to the petrous bone or transverse-sigmoid sinus),23 chemosis and proptosis (for carotid cavernous fistulas due to congestion of the ophthalmic veins),24 progressive early-onset dementia (due to congestion of the deep venous system of the diencephalon and striatum),25 and seizures (due to congestion of the superficial venous system of the cortex).2 A background history of dural venous sinus thrombosis, intracranial infection, cranial surgery, or head trauma may also be suggestive.13 Hemorrhagic presentation is typically with sudden onset of severe headache, seizures, focal neurologic deficits, or loss of consciousness.13
Noncontrast Imaging.
Noncontrast imaging findings suggestive of a nonhemorrhagic dAVF include serpiginous dilated cortical veins (mildly hyperattenuating on noncontrast CT, hypointense T2/FLAIR flow voids on MR imaging), vasogenic edema secondary to venous congestion, and dilated transosseous vascular channels (particularly in the temporal and occipital bones) best appreciated on the bone window settings of CT imaging (Fig 2A).26,27 This latter finding is also useful to distinguish a pial vascular malformation from a dAVF (because only the latter would be supplied by enlarged transosseous arterial vessels).27
Clinical presentation of nonhemorrhagic dAVFs with seizures is typically associated with superficial venous congestion, which, on noninvasive imaging, is characterized by vasogenic edema in the subcortical white matter and enlarged T2 FLAIR serpiginous flow voids over the cerebral convexities.2 Clinical presentation with dementia is typically associated with deep venous congestion, characterized by edema in the thalami/basal ganglia, as well as ventriculomegaly.25 Pulsatile tinnitus as a presenting symptom usually indicates proximity of the fistula to the petrous temporal bone or sigmoid sinus and is seen with fistulas involving the transverse-sigmoid sinuses, petrous ridge, or hypoglossal canal.23 Proptosis and chemosis, usually associated with carotid cavernous dAVFs, will typically manifest on imaging with enlarged superior ophthalmic veins.24
Noncontrast imaging findings in hemorrhagic dAVFs can include subdural, subarachnoid, intraparenchymal, and/or intraventricular hemorrhage.28 A particularly suggestive finding is the combination of subdural and intraparenchymal hemorrhage; this pattern occurs most commonly with traumatic brain injury; but outside the setting of trauma, it should raise suspicion of a dAVF.28⇓-30 Aneurysmal or parenchymal AVMs related to hemorrhage may involve the intraparenchymal and subarachnoid spaces but usually do not rupture the arachnoid mater to enter the subdural space.28 In dAVFs, however, enlarged cortical veins traverse the subarachnoid and subdural spaces; thus, venous rupture can be associated with this otherwise uncommon pattern outside the setting of trauma.29,30
TOF-MRA is a useful initial vascular imaging technique for detection of high-flow dAVFs.31 The typical suppression of caudally directed venous flow undertaken to acquire TOF-MRA without venous contamination is useful in detecting abnormal early venous filling as a result of dAVFs.32 High-flow AVFs, as a result of transmission of intravascular protons that have undergone excitation in a caudal section directly into cortical veins or dural venous sinuses, can thus result in abnormal hyperintense signal within intracranial venous structures.33 Examples of this are demonstrated in Figs 2B and 3D.
Contrast-Enhanced Noninvasive Imaging.
CT angiography and gadolinium-enhanced MR angiography are useful in demonstrating early venous filling in dAVFs but require precise timing of image acquisition relative to the administration of the contrast bolus to ensure that venous enhancement is truly a result of arteriovenous shunting rather than venous contamination from late timing.34 A classic imaging finding in carotid cavernous fistulas is asymmetric cavernous sinus enhancement on CT angiography, often in association with enlargement of the superior ophthalmic vein.35 Contrast-enhanced CT and MR imaging are also both useful for demonstrating venous congestion and indirect evidence of cortical venous reflux, characterized by enlarged tortuous pial veins over the cerebral or cerebellar convexities (Fig 2C). The presence of venous congestion and cortical venous reflux would also be supported by ipsilateral white matter vasogenic edema and enlarged serpiginous surface vessels on precontrast CT or T2 FLAIR sequences.
Time-resolved gadolinium-enhanced MR angiography is a particularly useful noninvasive imaging tool for the characterization of dAVFs because it allows assessment of the contrast bolus in multiple phases.36 The use of 4D CTA is also increasing for this diagnostic purpose.37
DSA.
Ultimately, DSA is the criterion standard for the diagnosis and assessment of dAVFs.38 In our practice, we use 6-vessel cerebral angiography, including assessment of the upper neck and facial structures within the FOV as appropriate, to ensure identification of all the important arterial feeders to the AVF and to fully appreciate the venous drainage pattern and impact on the venous drainage of the normal brain parenchyma. In addition, we use a magnified high-frame-rate (typically 6 frames per second) DSA centered on the fistulous point to fully understand the angioanatomy, architecture, and flow dynamics of the fistula. The use of 3D rotational angiography with reconstruction of the volumetric acquisition in multiple planes (essentially creating a conebeam CTA with intra-arterial injection), timed to demonstrate the arterial feeders and the venous drainage pathway, allows detailed assessment of all arterial feeders and their relationship to the skull base foramina.39 A sample case involving the facial arcade is demonstrated in Fig 3.
These additional techniques allow us to identify external carotid artery (ECA)-ICA anastomoses and cranial nerve arterial supplies that may be at risk during endovascular treatment and thus reduce our treatment-related risk profile. Selective injection of the ascending pharyngeal artery, occipital artery, and/or the internal maxillary artery is often useful (in combination with selective 3D rotational angiography) to demonstrate important arterial feeders that may not be appreciated when there is shunting across multiple other arterial supply points.40 An example of the utility of such selective injection is for identification of the facial nerve arterial arcade (in particular the petrous branch of the middle meningeal artery) via internal maxillary or middle meningeal artery injection for assessment of petrous AVFs,41 in which there are often multiple competing occipital artery feeders obscuring the arcade on more proximal ECA injections. The utility of 3D rotational angiography is demonstrated in Fig 3B, -C.
Management
Our management of dAVFs is guided by 2 main principles:
Detailed anatomic assessment (based on DSA findings)
Multidisciplinary discussion.
Detailed Anatomic Assessment.
We undertake detailed anatomic assessment of the DSA imaging (including 3D rotational angiography with MPRs) to assist in management decision-making via a 4-step process:
Benign vs aggressive: We determine whether the AVF is angiographically benign or aggressive on the basis of the absence or presence of cortical venous reflux/drainage.
Arterial supply and venous drainage: We determine all visible arterial supplies to the AVF, the location of the fistulous point, and the primary venous drainage points. Cure of the AVF via embolization will be dependent on successful occlusion of the fistulous point and the foot of the draining vein.
Risk from a transarterial (TA) embolization approach: Based on the arterial supply, we determine the risk of cranial nerve palsy or potential embolization across ECA-ICA anastomoses that would be associated with a TA embolization approach (eg, an AVF supplied primarily by branches of the neuromeningeal division of the ascending pharyngeal artery would pose a high risk of cranial nerve IX, X, and XII palsy via a transarterial approach). These risks are discussed in detail in the second article of this series focused on TA embolization.
Risk from a transvenous (TV) embolization approach: Based on the venous drainage pattern, we determine the risk of intracranial hemorrhage, venous infarction, or long-term intracranial venous hypertension that would be associated with a TV embolization approach (eg, in a patient with a single/dominant transverse sinus, coil occlusion of that sinus for treatment of an AVF may pose a long-term risk of venous hypertension). These risks are discussed in detail in the third article of this series focused on TV embolization.
Multidisciplinary Discussion.
We discuss all new AVF cases at our monthly multidisciplinary neurovascular meeting, attended by interventional neuroradiologists, cerebrovascular surgeons, vascular neurologists, and gamma knife radiosurgeons. In emergent cases requiring more rapid decision-making (eg, clinical presentation with intracranial hemorrhage or progressive nonhemorrhagic neurologic deficits), the management discussion is undertaken acutely among the admitting cerebrovascular surgeon, the on-call interventional neuroradiologist, and, when appropriate (eg, presentation with seizures), the treating vascular neurologist. The advantages of multidisciplinary discussion include the potential range of management options that can be considered as well as engagement of all relevant specialties early in the treatment course.
Decision to Offer Interventional Treatment.
The first and most important decision made during the multidisciplinary discussion is whether the patient requires interventional treatment of the AVF or conservative management with clinical and imaging follow-up. This decision is based primarily on the venous drainage pattern and the associated natural history, ie, whether the AVF has a benign or aggressive venous drainage pattern. All patients with aggressive venous drainage patterns should be offered treatment because of the poor natural history.
In patients with benign drainage patterns, interventional treatment may still be offered if the symptoms cause significant functional disability and the patient is willing to accept the risks of intervention to reduce that disability (eg, severe pulsatile tinnitus can interfere with sleep and quality of life, in some cases contributing to mood disorders and even suicide). For patients with benign drainage patterns and tolerable symptoms, we recommend conservative management with annual clinical and imaging follow-up (because benign drainage patterns can transform into aggressive patterns with time in approximately 2%–4% of patients).2,8,13,20
The major risk factor for conversion from benign to aggressive drainage is spontaneous thrombosis of the ipsilateral draining vein, which may be heralded by a change (increase or decrease) in the patient’s symptoms.2,13,20 Such change in symptoms warrants earlier follow-up and imaging.2 In our practice, we use contrast-enhanced time-resolved MR angiography for follow-up of conservatively managed patients because it allows noninvasive assessment of the intracranial circulation in multiple phases and has a high sensitivity for detecting aggressive venous drainage patterns.36,42 In patients with contraindications for MR imaging, 4D CTA is also an option to avoid repeat invasive DSAs.37
Treatment Options.
For patients in whom interventional treatment is indicated, 4 major treatment options are available:
TA embolization
TV embolization
Microsurgical disconnection
Gamma knife radiosurgery (GKRS).
Endovascular Approaches.
At our institution, we have adopted an endovascular-first approach to treating intracranial AVFs when possible, based on improving angiographic and clinical cure rates because technology and strategies have evolved in the past 2 decades.43 A major technologic advancement was the development of modern liquid embolic agents (in particular, ethylene-vinyl alcohol copolymer) that allow embolization in a more controlled fashion than ethanol or glue, resulting in higher angiographic cure rates.43,44 The use of these agents has resulted in modified endovascular treatment strategies, in which plug formation, dual microcatheter techniques (pressure cooker), or flow arrest via a dual-lumen balloon are used to allow antegrade (for TA approaches) or retrograde (for TV approaches) controlled advancement of the embolic agent to occlude the fistulous point.44⇓⇓-47
Detailed descriptions of the techniques used during TA and TV embolization are provided in the second and third articles of this series.
Microsurgical Disconnection.
In cases in which the estimated risks associated with TA and/or TV embolization are elevated, microsurgical disconnection is an effective treatment option. In this setting, multidisciplinary discussion is particularly useful to weigh the risks and benefits of endovascular-versus-surgical approaches. We have frequently encountered cases in which the endovascular approach is difficult and associated with a high risk of cranial nerve palsy or stroke, while being a relatively simple case for microsurgical disconnection (eg, petrous AVFs involving the facial nerve arterial arcade or anterior cranial fossa AVFs supplied by ethmoidal branches of the ophthalmic artery). The surgical goal is to disconnect the draining vein of the AVF using aneurysm clips or ligation.48 Even if achieving this surgical goal does not result in angiographic cure, it will usually result in disconnection of the dangerous aspect of the AVF, the cortical venous reflux, thus converting an aggressive AVF into a benign one.19,48
However, the invasive nature of open surgical approaches is associated with potential complications that are often avoided by endovascular approaches, such as CSF leak, pseudomeningocele formation, hydrocephalus, infection, and wound pain.14,19 In addition, the tissue disruption associated with an operation is a potential trigger for further dAVF development. A strong working relationship between interventional neuroradiologists and cerebrovascular surgeons is useful in selecting the most appropriate treatment approach for any given AVF, to minimize the risk of complications from either an endovascular or open surgical approach.
GKRS.
GKRS, while being an effective treatment option for parenchymal AVMs, has a more limited role in the treatment of dAVFs. In our experience, the long-term outcomes after GKRS for dAVFs are suboptimal (50% angiographic cure rate), and some patients require further treatment via 1 of the 3 main modalities above.49 GKRS is a useful alternative for symptom palliation in patients who have failed other treatments or are averse to endovascular/surgical intervention.43,49 An example of the utility of GKRS is reducing the severity of pulsatile tinnitus in patients with incurable or recurrent transverse sinus AVFs.49
CONCLUSIONS
Intracranial dAVFs are stratified by the absence or presence of cortical venous reflux. These lesions are best managed using the principles of detailed angiographic anatomic assessment and multidisciplinary discussion. We detail TA and TV embolization techniques in our next 2 articles.
Footnotes
Disclosures: Timo Krings—UNRELATED: Consultancy: Stryker, Penumbra, Medtronic, Cerenovus Royalties: Thieme; Stock/Stock Options: Marblehead.
Indicates open access to non-subscribers at www.ajnr.org
References
- Received February 2, 2021.
- Accepted after revision July 7, 2021.
- © 2022 by American Journal of Neuroradiology